CD36 as a marker of acute myeloid leukemia prognosis: A systematic review
CD36 is a glycoprotein associated with resistance to chemotherapy and the recurrence of acute myeloid leukemia. This systematic review aims to evaluate the impact of CD36 on the prognosis of acute myeloid leukemia, a complex heterogeneous malignant hematopoietic disease. The Embase, Scopus, Web of S...
Saved in:
| Main Authors: | Marina Chaves Amantéa, Rafaela Pires da Silva, Larissa Ranini Soares, João Lorenzo de Medeiros Pereira, Ana Paula Duarte de Souza |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137925001294 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-macrophages targets CD26 to eliminate chronic myeloid leukemia stem cells
by: Jiang Guoyun, et al.
Published: (2025-02-01) -
CD155 as a prognostic and predictive biomarker in acute myeloid leukemia
by: Ashraf Zeidan Abdalla, et al.
Published: (2025-05-01) -
Disulfidptosis-related LncRNAs forecast the prognosis of acute myeloid leukemia
by: Pei Xu, et al.
Published: (2025-04-01) -
A novel LncRNA risk model for disulfidptosis-related prognosis prediction and response to chemotherapy in acute myeloid leukemia
by: Yihong Wei, et al.
Published: (2025-05-01) -
Mass screening for CD36 antigen expression and analysis of negative donor structure and supply capacity
by: XU Yunping, et al.
Published: (2025-05-01)